Arg-Pro-Leu-Lys-Pro-Trp

Known as: RPLKPW peptide, arginyl-prolyl-leucyl-lysyl-prolyl-tryptophan, novokinin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
02420082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Cumulative data suggest the significant role of the renin-angiotensin system in the development of the pathological consequences… (More)
Is this relevant?
2016
2016
BACKGROUND/AIM The effects of AT2 receptor agonist novokinin on blood pressure, eNOS, NADPH oxidase, protein arginine… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Novokinin is a vasorelaxing peptide designed according to the structure of ovokinin(2-7) that is released from ovalbumin by… (More)
Is this relevant?
2013
2013
Novokinin (RPLKPW) was designed based on ovokinin (FRADHPFL), a vasorelaxing peptide derived from ovalbumin. Novokinin relaxed a… (More)
Is this relevant?
2011
2011
Novokinin (Arg-Pro-Leu-Lys-Pro-Trp, RPLKPW) is a new potent antihypertensive peptide based on the sequence of ovokinin (2-7… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Novokinin (Arg-Pro-Leu-Lys-Pro-Trp), having affinity for the AT(2) receptor, is a potent vasorelaxing and hypotensive peptide… (More)
Is this relevant?
2008
2008
Novokinin (RPLKPW), LPYPR, and rubiscolin (YPLDLF) are bioactive peptides with respective hypotensive, hypocholesterolemic, and… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
Novokinin (Arg-Pro-Leu-Lys-Pro-Trp) is a potent hypotensive peptide previously designed based on the structure of ovokinin(2-7… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2008
2008
Novokinin (Arg-Pro-Leu-Lys-Pro-Trp), which has been designed based on the structure of ovokinin (2-7), significantly reduces the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
In this study, we found that novokinin (Arg-Pro-Leu-Lys-Pro-Trp), a potent hypotensive peptide acting through the AT(2) receptor… (More)
Is this relevant?